Mindfulness-Based Interventions for Adolescent Substance Use and Substance Use Disorders: A Systematic Review.
Pediatrics February 1, 2026
Mindfulness-Based Interventions for Adolescent Substance Use and Substance Use Disorders: A Systematic Review.
ISSN 0031-4005
8 papers in the library · 735 citations · publishing 1970-2026
Pediatrics February 1, 2026
Mindfulness-Based Interventions for Adolescent Substance Use and Substance Use Disorders: A Systematic Review.
Pediatrics April 1, 2020 A. Weitlauf, Neill Broderick, J. A. Stainbrook et al.
This study examined whether parents of children with ASD reported better functioning if they received stress-reduction training as part of early behavioral intervention. BACKGROUND AND OBJECTIVES: Systems of care emphasize parent-delivered intervention for children with autism spectrum disorder (ASD). Meanwhile, multiple studies document psychological distress within these parents. This pilot...
Pediatrics December 19, 2015 Erica Sibinga, Lindsey Webb, Sharon R. Ghazarian et al. 233 citations
BACKGROUND AND OBJECTIVE: Many urban youth experience significant and unremitting negative stressors, including those associated with community violence, multigenerational poverty, failing educational systems, substance use, limited avenues for success, health risks, and trauma. Mindfulness instruction improves psychological functioning in a variety of adult populations; research on mindfulness...
Pediatrics August 21, 2012 Lynn T. Singer, David G. Moore, Meeyoung O. Min et al. 49 citations
OBJECTIVE: A widely used illicit recreational drug among young adults, 3,4-methylenedioxymethamphetamine (MDMA) or ecstasy, is an indirect monoaminergic agonist/reuptake inhibitor affecting the serotonin system. Preclinical studies found prenatal exposure related to long-term learning and memory impairments. There are no studies of sequelae of prenatal MDMA exposure in humans, despite potential...
Pediatrics August 24, 2009 David S. Black, Joel Milam, Steve Y Sussman 266 citations
OBJECTIVE: Although the efficacy of meditation interventions has been examined among adult samples, meditation treatment effects among youth are relatively unknown. We systematically reviewed empirical studies for the health-related effects of sitting-meditative practices implemented among youth aged 6 to 18 years in school, clinic, and community settings. METHODS: A systematic review of...
Pediatrics November 1, 2006 Rüssel S. Falck, Linna Li, Robert H. Carlson et al. 19 citations
To the Editor.—Dextromethorphan is the d-isomer of the codeine analog, levorphanol, and the active ingredient in >100 over-the-counter cough and cold preparations. Reports of dextromethorphan abuse date back to the 1960s.1,2 There is some evidence suggesting that when used inappropriately at very high doses (eg, 1500 mg/day), dextromethorphan can result in a dependence-like syndrome.2...
Pediatrics October 1, 1997 Richard H. Schwartz, Norman S. Miller 155 citations
The drug 3,4 methylenedioxymethamphetamine (MDMA), also known as "ecstasy," is a "designer" drug that is becoming popular with American adolescents at dance halls known as "raves" and on college campuses. An analogue of amphetamine, MDMA shares properties with both amphetamine and hallucinogenic drugs. Now available in many US cities, MDMA has an undeserved reputation for safety and a long...
Pediatrics March 1, 1970 Richard J. Warren, David L. Rimoin, William S. Sly 13 citations
In spite of the many recent reports on the damaging effects of LSD on human chromosome in vitro1,2 and in vivo3-6 and its ability to produce congenital malformations in rodents7, the teratogenic potential of this drug in humans is still uncertain. Two infants with limb malformations who had been exposed to LSD in utero have thus far been reported8,9. On the other hand, Cohen, et al.5, reported...